Author

Jin-A Lee

Boston University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:statistical model· 1

Frequent Co-Authors

Boyoung LeeiD· 1 shared Changjoon Justin LeeiD· 1 shared Da-ha Park· 1 shared Daniel Youngjae Park· 1 shared Eun Hye ChoiD· 1 shared Gee Eun LeeiD· 1 shared Haneul ChoiiD· 1 shared Hee Yeon Kim· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Boyoung LeeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Hyperactivation of the AXL-ICD/SIRT2 axis by Amyloid-β impairs astrocytic autophagic flux and exacerbates neuroinflammation

Tai Young Kim, Mridula Bhalla, Uiyeol Park, Seung Jae Hyeon, In‐Young Hwang, Youngsuk Seo, Wongu Youn, Jin-A Lee, Jung-Hee Lee, Boyoung Lee, Hoon Ryu, Changjoon Justin Lee

This study identifies the AXL-ICD/SIRT2 axis as a mechanism by which amyloid-β impairs astrocytic autophagy and exacerbates neuroinflammation in Alzheimer's disease.

bioRxiv · Aug 31, 2026 · PreprintNeuroscience

Targeted degradation of pathogenic TDP-43 proteins in amyotrophic lateral sclerosis using the AUTOTAC platform

Daniel Youngjae Park, Hee Yeon Kim, Eun Hye Cho, Haneul Choi, Da-ha Park, Gee Eun Lee, Sung Hyun Kim, Hye Yeon Kim, Young Ho Suh, Jin-A Lee, Yong Tae Kwon

This paper develops AUTOTAC degraders to target and degrade pathogenic TDP-43 aggregates in ALS, showing efficacy in mice and entering clinical trials.

bioRxiv · Aug 31, 2025 · PreprintNeuroscience